The information in these pages is taken from the press releases that correspond
to each fiscal quarter ended and should not be deemed accurate or current ...
Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on ...
Perhaps time to learn more. ... Gilead's blockbuster hepatitis C virus (HCV) drug
Harvoni should ... Here are a couple of other health care stocks that you may
want to ... Biotech Stock Roundup: Actelion Soars on Acquisition Talks, ...
Sep 22, 2016 ... Does Gilead Sciences' falling share price offer an opportunity to buy, or should ...
six different drugs that are selling at billion-dollar blockbuster clip or better. ... it
was only available briefly in the quarter, Epclusa sales were $61 million. ... 5
Things Gilead Sciences' CEO Just Said That You Need to Kn...
Mar 2, 2016 ... The fourth quarter earnings season is winding down, with quite a few ... Gilead,
known for its strong presence in the HIV and hepatitis C virus ... HIV treatments to
market and to boost sales of its blockbuster HIV franchise. ... With limited
treatments being available, there is significant unmet need in this area.
Feb 10, 2015 ... In McKesson's second 2015 fiscal quarter (2014's third calendar ... Consider
Gilead Sciences' Sovaldi, the hepatitis C drug approved in December 2013. ... To
understand wholesaler pricing models, see Chapter 4 of the ... You may be
tempted to view specialty drugs as automatically good for wholesalers.
Nov 16, 2016 ... Gilead HBV Drug Gains FDA Approval: Gilead GILD, which is facing ... While both
drugs have been touted as having blockbuster potential, ... With third quarter
earnings season drawing to a close, watch out for pipeline and regulatory
updates. ... Today, you can download 7 Best Stocks for the Next 30 Days.
Oct 31, 2016 ... Moreover, for the quarter, Gilead has an Earnings ESP of +0.37%. ... In the
upcoming quarterly earnings call, investor focus should be on the ... Please
check our Earnings ESP Filter that enables you find stocks that are ... Biotech
Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed ...
Jun 29, 2016 ... Meanwhile, Gilead continues to expand its blockbuster HCV franchise. ... for the
duvelisib program, and will focus on submitting a NDA in the fourth quarter of
2016. .... Ever have one of those situations where you find out your brown-
bagging .... Social Security Taxes Will Nick More of Your Earnings in 2017.
Apr 30, 2015 ... April, 2015; Gilead CEO: “We are taking suggestions” on companies to buy ... of
the Affordable Care Act every business leader needs to know about ... Time
Warner Cable adds more subscribers, but earnings slip ... Better than you think.
.... Apple's blockbuster quarter: What the analysts are saying - updated ...